Morgan Stanley Upgrades Sasol To Overweight, Says Valuation Failing To Price In Near-Term Catalyst

Morgan Stanley upgraded Sasol Limited (ADR) SSL to Overweight from Equal-weight, saying that recent underperformance offers an attractive entry point to play a medium-term cyclical recovery in oil price.

Near-term U.S. chemical project capex downside is priced in and share appears to assign little eventual project upside value," analyst Christopher Nicholson wrote in a note.

The analyst noted the market is assigning very little upside to the Lake Charles Chemical Project (LCCP) in the US.

Nicholson forecast a 5-year 13 percent CAGR in EPS, the bulk (11pp) being driven by project uplift and cost savings. Further, the estimated FY16 dividend yield of 4 percent is attractive versus the SA market, and remains so even under conservative forward payout assumptions.

On the valuation front, the analyst said Sasol trades at 8.7x forward consensus P/E, and at a discount to its historical long-term average of 9.7x. At spot, Sasol trades at a still reasonable 10.5x forward P/E – in particular given relatively robust chemical margins and the premium valuation of chemical peers.

At time of writing, ADRs of Sasol rose 2.55 percent to $28.10.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorUpgradesPrice TargetAnalyst RatingsChristopher NicholsonMorgan Stanley
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!